Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy.

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy. Haematologica. 2018 Sep 06;: Authors: Eyre TA, Walter HS, Iyengar S, Follows G, Cross M, Fox CP, Hodson A, Coats J, Narat S, Morley N, Dyer MJS, Collins GP PMID: 30190341 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30190341?dopt=Abstract

Source: Haematologica - September 6, 2018 Category: Hematology Authors: Eyre TA, Walter HS, Iyengar S, Follows G, Cross M, Fox CP, Hodson A, Coats J, Narat S, Morley N, Dyer MJS, Collins GP Tags: Haematologica Source Type: research

More News: Hematology | Lymphoma